Abstract

BackgroundExcisional procedures of cervical intraepithelial neoplasia (CIN) may increase the risk of preterm birth. It is unknown whether this increased risk is due to the excision procedure itself, to the underlying CIN, or to secondary risk factors that are associated with both preterm birth and CIN. The aim of this study is to assess the risk of spontaneous preterm birth in women with treated and untreated CIN and examine possible associations by making a distinction between the excised volume of cervical tissue and having cervical disease.Methods and findingsThis Dutch population-based observational cohort study identified women aged 29 to 41 years with CIN between 2005 and 2015 from the Dutch pathology registry (PALGA) and frequency matched them with a control group without any cervical abnormality based on age at and year of pathology outcome (i.e., CIN or normal cytology) and urbanization (<100,000 inhabitants or ≥100,000 inhabitants). All their 45,259 subsequent singleton pregnancies with a gestational age ≥16 weeks between 2010 and 2017 were identified from the Dutch perinatal database (Perined). Nineteen potential confounders for preterm birth were identified. Adjusted odds ratios (ORs) were calculated for preterm birth comparing the 3 different groups of women: (1) women without CIN diagnosis; (2) women with untreated CIN; and (3) women with treated CIN prior to each childbirth.In total, 29,907, 5,940, and 9,412 pregnancies were included in the control, untreated CIN, and treated CIN group, respectively. The control group showed a 4.8% (1,002/20,969) proportion of spontaneous preterm birth, which increased to 6.9% (271/3,940) in the untreated CIN group, 9.5% (600/6,315) in the treated CIN group, and 15.6% (50/321) in the group with multiple treatments. Women with untreated CIN had a 1.38 times greater odds of preterm birth compared to women without CIN (95% confidence interval (CI) 1.19 to 1.60; P < 0.001). For women with treated CIN, these odds 2.07 times increased compared to the control group (95% CI 1.85 to 2.33; P < 0.001). Treated women had a 1.51 times increased odds of preterm birth compared to women with untreated CIN (95% CI 1.29 to 1.76; P < 0.001). Independent from cervical disease, a volume excised from the cervix of 0.5 to 0.9 cc increased the odds of preterm birth 2.20 times (37/379 versus 1,002/20,969; 95% CI 1.52 to 3.20; P < 0.001). These odds further increased 3.13 times and 5.93 times for women with an excised volume of 4 to 8.9 cc (90/724 versus 1,002/20,969; 95% CI 2.44 to 4.01; P < 0.001) and ≥9 cc (30/139 versus 1,002/20,969; 95% CI 3.86 to 9.13; P < 0.001), respectively. Limitations of the study include the retrospective nature, lack of sufficient information to calculate odds of preterm birth <24 weeks, and that the excised volume could only be calculated for a select group of women.ConclusionsIn this study, we observed a strong correlation between preterm birth and a volume of ≥0.5 cc excised cervical tissue, regardless of the severity of CIN. Caution should be taken when performing excisional treatment in women of reproductive age as well as prudence in case of multiple biopsies. Fertile women with a history of performing multiple biopsies or excisional treatment for CIN may benefit from close surveillance during pregnancy.

Highlights

  • The introduction of cervical cancer screening programs has drastically decreased the incidence and mortality from cervical cancer, due to early treatment of high-grade cervical intraepithelial neoplasia (CIN) [1]

  • In this population-based study, including 45,259 pregnancy outcomes, we observe that both women with untreated CIN and treated CIN have an increased odds of spontaneous preterm birth compared to women without a CIN diagnosis

  • Logistic regression for preterm birth for women with no CIN, untreated CIN, and treated CIN before each childbirth. aWith adjustment for age at childbirth, year of childbirth, urbanization, ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric diseases, history of abortion, history of preterm birth, pregnancy by in vitro fertilization (IVF), nulliparous women, pre-eclampsia, gestational diabetes, placental abruption, placenta or vasa previa, congenital diseases, intrauterine growth restriction, macrosomia, stillbirth, and fetal distress. bWomen with induction of labor were excluded from analysis. cTo adjust for multiple testing, we considered a P value of

Read more

Summary

Introduction

The introduction of cervical cancer screening programs has drastically decreased the incidence and mortality from cervical cancer, due to early treatment of high-grade cervical intraepithelial neoplasia (CIN) [1]. Women participating in the screening program may undergo biopsy or treatment within their reproductive age, as the incidence of CIN peaks at around the age of 30. Research has shown that excisional procedures of CIN may increase the risk of adverse pregnancy outcomes, such as preterm birth, preterm premature rupture of membranes (pPROM), and less favorable neonatal outcomes as a direct result of prematurity [2,3,4,5]. Screening programs are replacing primary cytology testing by primary high-risk human papillomavirus (hrHPV) testing, resulting in higher referral rates and more women undergoing biopsy or treatment [6], which may further increase the number of women at risk for adverse pregnancy outcomes

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call